BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 [PMID: 30588287 DOI: 10.4239/wjd.v9.i12.252]
URL: https://www.wjgnet.com/1948-9358/full/v9/i12/252.htm
Number Citing Articles
1
Taylor J. Clegg, Noor Kawmi, Nicholas M. Graziane. Different classes of antibiotics have varying effects on the risk of developing opioid use disorder: a national database studyJournal of Substance Use 2023; 28(1): 101 doi: 10.1080/14659891.2021.2010140
2
Brittany N Franco, Shinichi Asano. COVID-19-Related Trends and Characteristics of Type 2 Diabetes Mellitus and Metabolic SyndromeCureus 2022;  doi: 10.7759/cureus.21483
3
Brandon Muncan, Alan Abboud, Aikaterini Papamanoli, Mark Jacobs, Allison J. McLarty, Hal A. Skopicki, Andreas P. Kalogeropoulos. Five-Year Cardiovascular Outcomes after Infective Endocarditis in Patients with versus without Drug Use HistoryJournal of Personalized Medicine 2022; 12(10): 1562 doi: 10.3390/jpm12101562
4
Dennis B. Campbell, David J.T. Campbell, Flora Au, Reed F. Beall, Paul E. Ronksley, Derek S. Chew, Yewande Ogundeji, Braden J. Manns, Brenda R. Hemmelgarn, Marcello Tonelli, Amity E. Quinn. Patterns and Patients’ Characteristics Associated With Use of Sodium-Glucose Cotransporter-2 Inhibitors Among Adults With Type 2 Diabetes: A Population-based Cohort StudyCanadian Journal of Diabetes 2023; 47(1): 58 doi: 10.1016/j.jcjd.2022.08.002
5
Kristen M. Tecson, Scott S. Shafiei. Textbook of Cardiorenal Medicine2021; : 315 doi: 10.1007/978-3-030-57460-4_24
6
Jesper Krogh, Carsten Hjorthøj, Søren L. Kristensen, Christian Selmer, Steen B. Haugaard. The effect of sodium‐glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studiesDiabetic Medicine 2021; 38(9) doi: 10.1111/dme.14600
7
Shahrzad Salmasi, Oriana H.Y. Yu, Kristian B. Filion. Potential role of SGLT2 inhibitors in the management of hypertensionTrends in Cardiovascular Medicine 2022;  doi: 10.1016/j.tcm.2022.07.002
8
Paul J Harrison, Sierra Luciano, Lucy Colbourne. Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network studyJournal of Psychopharmacology 2020; 34(8): 848 doi: 10.1177/0269881120936501
9
Jacques Baillargeon, Efstathaia Polychronopoulou, Yong-Fang Kuo, Mukaila A. Raji. The Impact of Substance Use Disorder on COVID-19 OutcomesPsychiatric Services 2021; 72(5): 578 doi: 10.1176/appi.ps.202000534
10
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with DementiaDrugs & Aging 2021; 38(7): 593 doi: 10.1007/s40266-021-00863-5
11
Peter Shafeek, Taylor Clegg, Noor Kawmi, Sierra Luciano, Curtis Bone, Nicholas Graziane. The temporal relationship between antibiotic and opioid prescription on the risk of developing an opioid use disorder: A national database studyJournal of Addictive Diseases 2022; : 1 doi: 10.1080/10550887.2022.2108364
12
Emily R Pfaff, Andrew T Girvin, Davera L Gabriel, Kristin Kostka, Michele Morris, Matvey B Palchuk, Harold P Lehmann, Benjamin Amor, Mark Bissell, Katie R Bradwell, Sigfried Gold, Stephanie S Hong, Johanna Loomba, Amin Manna, Julie A McMurry, Emily Niehaus, Nabeel Qureshi, Anita Walden, Xiaohan Tanner Zhang, Richard L Zhu, Richard A Moffitt, Melissa A Haendel, Christopher G Chute, William G Adams, Shaymaa Al-Shukri, Alfred Anzalone, Ahmad Baghal, Tellen D Bennett, Elmer V Bernstam, Elmer V Bernstam, Mark M Bissell, Brian Bush, Thomas R Campion, Victor Castro, Jack Chang, Deepa D Chaudhari, Wenjin Chen, San Chu, James J Cimino, Keith A Crandall, Mark Crooks, Sara J Deakyne Davies, John DiPalazzo, David Dorr, Dan Eckrich, Sarah E Eltinge, Daniel G Fort, George Golovko, Snehil Gupta, Melissa A Haendel, Janos G Hajagos, David A Hanauer, Brett M Harnett, Ronald Horswell, Nancy Huang, Steven G Johnson, Michael Kahn, Kamil Khanipov, Curtis Kieler, Katherine Ruiz De Luzuriaga, Sarah Maidlow, Ashley Martinez, Jomol Mathew, James C McClay, Gabriel McMahan, Brian Melancon, Stephane Meystre, Lucio Miele, Hiroki Morizono, Ray Pablo, Lav Patel, Jimmy Phuong, Daniel J Popham, Claudia Pulgarin, Carlos Santos, Indra Neil Sarkar, Nancy Sazo, Soko Setoguchi, Selvin Soby, Sirisha Surampalli, Christine Suver, Uma Maheswara Reddy Vangala, Shyam Visweswaran, James von Oehsen, Kellie M Walters, Laura Wiley, David A Williams, Adrian Zai. Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborativeJournal of the American Medical Informatics Association 2022; 29(4): 609 doi: 10.1093/jamia/ocab217
13
Robert James Trager, Shaffer R.S. Mok, Kayla J. Schlick, Jaime A. Perez, Jeffery A. Dusek. Association between radicular low back pain and constipation: a retrospective cohort study using a real-world national databasePAIN Reports 2021; 6(3): e954 doi: 10.1097/PR9.0000000000000954
14
Zachary G. Freedman, Jennifer A. Kane, Tonya S. King, Nicholas M. Graziane. The effect of prescribing antibiotics with opioids on the development of opioid use disorder: a national database studyJournal of Addictive Diseases 2022; 40(1): 62 doi: 10.1080/10550887.2021.1926889
15
Mario Enrico Canonico, Judith Hsia, Christopher P. Cannon, Marc P. Bonaca. Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney DiseaseJACC: Heart Failure 2022; 10(12): 989 doi: 10.1016/j.jchf.2022.09.013
16
Haijiang Dai, Arwa Younis, Jude Dzevela Kong, Luca Puce, Georges Jabbour, Hong Yuan, Nicola Luigi Bragazzi. Big Data in Cardiology: State-of-Art and Future ProspectsFrontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.844296
17
Ameur M. Manceur, Mike Durkin, Akshay Kharat, Brahim Bookhart, Marie-Hélène Lafeuille, Dominic Pilon, Iman Fakih, Patrick Lefebvre. Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trialCurrent Medical Research and Opinion 2020; 36(4): 563 doi: 10.1080/03007995.2019.1708285
18
Francisco Batel-Marques, Diogo Pereira, Diogo Mendes, Carlos Alves, Ana Penedones. Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic reviewBMJ Open 2019; 9(9): e032522 doi: 10.1136/bmjopen-2019-032522